Business Segments · Litigation expense

General Corporate — Litigation expense

Analysis

StatementSegment
CategoryRisk
SignalLower is better
VolatilityVolatile
First reportedQ1 2026
Last reportedQ1 2026
Rolls up toLegal settlement

How to read this metric

An increase signals higher legal risk or the recognition of significant settlement provisions, which negatively impacts profitability; a decrease suggests lower legal exposure.

Detailed definition

This metric tracks the costs associated with legal proceedings, settlements, and provisions for potential losses within...

Peer comparison

Similar to 'Legal Reserves' or 'Litigation Charges' reported by large-cap pharmaceutical or industrial firms facing regulatory or product liability scrutiny.

Metric ID: jnj_segment_general_corporate_litigation_expense

Historical Data

1 periods
 Q1 '26
Value$300.00M

Frequently Asked Questions

What is Johnson & Johnson's general corporate — litigation expense?
Johnson & Johnson (JNJ) reported general corporate — litigation expense of $300.00M in Q1 2026.
What does general corporate — litigation expense mean?
The total costs incurred for legal disputes and settlements at the corporate level.

Cookie Preferences

We use cookies for analytics. See our Privacy and Cookie Policy.